Wang Shuai, Zhou Tao, Zhai Jun-Peng, Wang Li-Hua, Chen Jing
Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University, Beijing, 100010, China.
Chin J Integr Med. 2014 Nov;20(11):865-9. doi: 10.1007/s11655-013-1538-z. Epub 2013 Oct 14.
To investigate the effects of Modified Sanhuang Decoction (, MSD) enema on the serum tumor necrosis factor alpha (TNF-α) and colonic mucosa interleukin-1β (IL-1β), interleukin-6 (IL-6) levels in experimental ulcerative colitis (UC) rats.
Forty-five male Wistar rats were randomly divided into 4 groups: normal group (n=12), model group (n=11), salazosulfapyridine (SASP) group (n=11) and MSD group (n=11). The UC model was induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol solution. Rats in the normal group and model group were clystered with 0.9% normal saline, while in the SASP group and MSD group were clystered with SASP and MSD enema, respectively. After drug administration (10 mL/kg body weight, for 7 days), colonic gross changes and colonic mucosa histology were observed, serum TNF-α and colonic mucosa IL-1β, IL-6 levels were tested by enzyme linked immunosorbent assay and radioimmunoassay, respectively.
As compared with the normal group, the experimental UC rats, the colonic mucosal damage index scores (CMDIs), histopathological scores (HS) and the serum TNF-α and colonic mucosa IL-1β, IL-6 levels significantly increased (P<0.05 or P<0.01). In the MSD and SASP groups, the ulcer area significantly reduced, and edema disappeared. The CMDIs, HS, the serum TNF-α and colonic mucosa IL-1β, IL-6 levels in the MSD and SASP groups significantly decreased (P<0.05 or P<0.01) compared with the model group. The CMDIs in the MSD group were lower than that in the SASP group (P<0.05), but there were no significant differences in HS, serum TNF-α or colonic mucosa IL-1β, IL-6 levels between the MSD and SASP groups.
MSD enema can improve colonic mucosa impairment and decrease serum TNF-α and colonic mucosa IL-1β, IL-6 levels in experimental UC.
探讨改良三黄汤灌肠对实验性溃疡性结肠炎(UC)大鼠血清肿瘤坏死因子α(TNF-α)及结肠黏膜白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)水平的影响。
将45只雄性Wistar大鼠随机分为4组:正常组(n=12)、模型组(n=11)、柳氮磺胺吡啶(SASP)组(n=11)和改良三黄汤组(n=11)。采用2,4,6-三硝基苯磺酸(TNBS)/乙醇溶液诱导UC模型。正常组和模型组大鼠用0.9%生理盐水灌肠,SASP组和改良三黄汤组大鼠分别用SASP和改良三黄汤灌肠。给药(10 mL/kg体重,共7天)后,观察结肠大体变化及结肠黏膜组织学情况,分别采用酶联免疫吸附测定法和放射免疫测定法检测血清TNF-α及结肠黏膜IL-1β、IL-6水平。
与正常组相比,实验性UC大鼠的结肠黏膜损伤指数评分(CMDI)、组织病理学评分(HS)以及血清TNF-α和结肠黏膜IL-1β、IL-6水平显著升高(P<0.05或P<0.01)。改良三黄汤组和SASP组溃疡面积明显缩小,水肿消失。与模型组相比,改良三黄汤组和SASP组的CMDI、HS、血清TNF-α和结肠黏膜IL-1β、IL-6水平显著降低(P<0.05或P<0.01)。改良三黄汤组的CMDI低于SASP组(P<0.05),但改良三黄汤组和SASP组在HS、血清TNF-α或结肠黏膜IL-1β、IL-6水平方面无显著差异。
改良三黄汤灌肠可改善实验性UC大鼠的结肠黏膜损伤,降低血清TNF-α和结肠黏膜IL-1β、IL-6水平。